Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Lead-in Study of Single-dose 0.7% YASO GEL Followed by a Phase 1 Randomized, Double-blind Dose-escalation Study to Assess Safety and Pharmacokinetics of 2% YASO GEL

NCT07281404 is registered in ClinicalTrials.gov with Yaso Therapeutics Corporation as lead sponsor.

NCT NCT07281404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Lead-in Study of Single-dose 0.7% YASO GEL Followed by a Phase 1 Randomized, Double-blind Dose-escalation Study to Assess Safety and Pharmacokinetics of 2% YASO GEL
Lead sponsor
Yaso Therapeutics Corporation
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
February 29, 2028
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-phase safety and pk study of a vaginal gel